During ACLC 2022, Dr. Noemi Reguart reviewed the data for MET-targeting TKIs and monoclonal antibodies for patients with METex14 skipping mutations, MET amplification, and MET overexpression. Read more
Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration
+more
Beyond sotorasib, dozens of small molecule inhibitors are being explored to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center summarize the KRAS trial landscape. Read more
In a Q&A with ILCN, Dr. William K. Evans weighs in on vaping and flavored tobacco regulations as well as cessation and prevention efforts. Read more
IASLC selects multidisciplinary slate of physicians to chair WCLC 2024 and announces last call for abstracts for TTLC 2023. Read more
US Food and Drug Administration approves two combinations for non-small cell lung cancer. Read more
Prof. Denis Horgan, executive director for the European Alliance for Personalised Medicine, writes that while the intentions behind the EU’s new cancer screening recommendations are laudable, they lack a roadmap for turning ideas into reality. Read more
In Part 2 of our series on non-traditional methods to help patients quit smoking, Dr. Deepti Behl says it is important for healthcare providers to encourage their patients to quit smoking using current best practices as well as any other safe modality the patient perceives as helpful. Read more
While the harmful effects of smoking are well known, the negative impacts of continued smoking after a cancer diagnosis are underappreciated. With Lung Cancer Awareness Month under way, the association aims to change that with its new statement on tobacco cessation. Read more
Drs. Stephanie Saw and Daniel Tan stress the importance of understanding the intricacies of HER2 testing in non-small cell lung cancer to optimize patient selection. Read more
Go2 Foundation coordinates educational events across the United States to improve lung cancer awareness; abstract submissions open for 2023 European Lung Cancer Congress; and registration begins for inaugural Texas Lung Cancer Conference. Read more